Café

© 2026 Longbridge｜Terms of Service Privacy Policy

NTLA

NTLA

12.8403.22%( +0.400 )

LongbridgeAI

Intellia Therapeutics shares are trading lower after Wolfe Research downgraded the stock from Peer Perform to Underperform rating and announced a $9 price target.

benzinga_article

Jul 16, 2026 at 09:40 AM

Intellia Therapeutics shares are trading lower after Wolfe Research downgraded the stock from Peer Perform to Underperform rating and announced a $9 price target.

Source: benzinga_article The copyright of this article belongs to the original author/organization.

The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.

Intellia Therap

NTLA.US

Open

--

High

--

Low

--

Prev Close

--

P/E^TTM

--

Market Cap

--